Save Comparison | Neogene Therapeutics Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. | ![]() Empirica Therapeutics Empirica Therapeutics is a company developing immunotherapies to treat cancers. | Cytonus Therapeutics Cytonus Therapeutics is a company specializing in immune-oncology and gene therapies. | ||
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2018 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Schlieren, CH HQ | Locations New York, US HQ Amsterdam, NL | Locations Hamilton, CA HQ | Locations HQ | Locations Maastricht, NL HQ |
Employees | Employees 16 | Employees 254% increase | Employees 260% decrease | Employees 2 | Employees 525% increase |
Twitter followers | Twitter followers 117 | Twitter followers N/A | Twitter followers 31 | Twitter followers 168 | Twitter followers 19 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 1.7 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 0.2 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 33.33% | Percentage of tweets with engagement (last 30 days) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 110m (4 months ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 548.8k (over 1 year ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 110m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 548.8k |
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
View companyEmpirica Therapeutics is a company developing immunotherapies to treat cancers.
View companyCytonus Therapeutics is a company specializing in immune-oncology and gene therapies.
View companyEpify is a company developing epigenetic biomarkers that control gene activity.
View company